Orion Health warns strong kiwi weighing on revenue, cash position
Orion Health is still on track to return to profit in 2018
Orion Health is still on track to return to profit in 2018
Orion Health, the health software developer, is still on track to return to profit in 2018, though the strength of the kiwi is crimping revenue in local currency terms and drained more cash than anticipated.
Chairman Andrew Ferrier told shareholders at the annual meeting in Auckland that the company's forecast for revenue growth of more than 20% in the year ending March 31, 2017, wouldn't be met because the New Zealand dollar had appreciated against a number of currencies, meaning Orion will get less when sales are converted back into local currency. That currency movement also weighed on Orion's cash position.
"The board remains of the view that we have sufficient funds and facilities to pursue our existing growth strategy," Ferrier said in notes published to the stock exchange. "We remain focused on driving to profitability and still believe we will reach profitability during the 2018 financial year."
In May, Orion said it aims to return to profit in 2018 after forgoing short-term earnings when it listed in 2014 to expand its global operations and that its cash reserves were enough to fund that growth with some $8 million of annual savings expected from restructuring its US business.
The software developer's operating cash outflow of $32.3 million was smaller than the $38.5 million outflow in 2015, and Orion had cash and equivalents of $58.9 million as at March 31. Spending on research and development rose 26% to $63 million.
Mr Ferrier today said steps to transition patient records to cloud-based applications and the US restructure put the company in a position to achieve profitable growth, and was pleased with improvements in R&D under newly defined lines of business.
Orion shares rose 2.5% to $3.69.
(BusinessDesk)
Click the hamburger symbol top right of our homepage to access the Rich List 2016 and other sections.